To address this, we reanalyzed single-nucleus RNA sequencing (snRNA-seq) datasets from postmortem PD brains, uncovering a significant reduction of CD169+ BAMs in affected individuals (Prashant et al., 2024). Here, SIGLEC1 is linked to Parkinson disease.